Address And Details

865 S Figueroa St , Los Angeles, CA 90017
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The Funds investment objective is to seek to provide high total return from current income and capital appreciation, through investment in debt securities denominated in the local currencies of various Emerging Market Countries. Under normal circumstances, the Fund invests at least 80% of the value of its net assets, plus any borrowings for investment purposes, in debt securities issued or guaranteed by non-financial companies, financial institutions and government entities in Emerging Market Countries (as defined in the paragraph below) denominated in the local currencies of an issuer, and in derivative instruments that provide investment exposure to such securities. If the Fund changes this investment policy, it will notify shareholders in writing at least 60 days in advance of the change. The Fund may invest in high yield or below investment grade bonds (commonly known as junk bonds), which are bonds rated below BBB by S&P Global Ratings or below Baa by Moodys Investors Service, Inc., or, if unrated, bonds deemed by the Funds investment advisor to be of comparable quality. Macroeconomic or geopolitical considerations that may affect an issuer, (IV) another security or instrument may offer a better investment opportunity, or (v) the portfolio should be rebalanced for diversification or portfolio weighting purposes.

Net Asset Value

as of 6:03 PM ET 09/24/2021


  • 1 Week
  • -0.80%
  • 1 Month
  • -0.91%
  • 3 Months
  • -2.91%
  • 1 Yr Return
  • +2.72%
  • 5 Yr Return
  • -4.82%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 97.24%
Other 2.69%
Cash 0.07%
Stocks 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 34.21 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 1.45 0.62 -2.42
Beta 0.69 0.86 1.15
R Squared 0.04 0.06 0.08
Std Deviation 12.31 11.65 11.90
Sharpe Ratio 0.37 0.21 n/a

Purchase Information

as of 6:03 PM ET 09/23/2021
Minimum Initial $2000
Minimum Additional $250
Minimum Initial IRA $500


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 05/31/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 05/31/2021
1 Year
  • +4.45%
  • +8.43%
+4.45% +8.43%
3 Year
  • +4.83%
  • +2.41%
+4.83% +2.41%
10 Year
  • +0.40%
  • +0.73%
+0.40% +0.73%
Life Of Fund
  • +1.38%
  • +1.49%
+1.38% +1.49%

Top 10 Holdings

Symbol Company Name % Of Assets

Recent Articles from TheStreet


Tim Collins on How to Trade Nikola

Technical setups and short interest make much hated name volatile, and therefore interesting.

Chinese Firms Should Face Faster US Stock Delisting Over Audit Rules, SEC Chairman Gary Gensler Tells Lawmakers

Jim Cramer: Gensler's Plate is Very Full

SEC Chairman is key player in efforts to rein in ceaseless financial engineering.

stocks rise asset management sh

Cramer's Mad Money Recap: Advanced Micro Devices, Nvidia, Thor

Jim Cramer has your game plan for next week, which he says will be the calm before the earnings season storm.

Jim Cramer: Starbucks Needs More Traffic in Stores

Starbucks Resists Union Effort in New York Region: Report

Starbucks reportedly said it will raise wages and benefits and a union isn’t needed, to employees at three stores in Buffalo New York.

Exxon Mobil

Exxon, Occidental, Baker Hughes Make Goldman Turnaround List

Exxon has 'reduced costs, surprised to the downside on capital spending, outperformed our expectations in downstream/chemicals,' Goldman said.


Jim Cramer is Tired of the Weak Response to Chip Shortages

Companies need to forget about help from Washington and step up to the plate.

Microsoft Lead

Why 'Sarge' Guilfoyle Isn't Selling His Microsoft

Sharp management and strength across its business lines are keys to software giant.

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Bret Jensen: Paratek Deal Shows Promise

While antibiotics are usually less profitable and slower to develop market share than other drugs, Paratek has a key factor in its favor.

Stocks Close Higher as Wall Street Dissects New Tax Laws

Stocks End Mixed Amid Evergrande Default Saga, Supply Chain Chaos

Evergrande's default saga, as well as mounting supply chain issues, have stocks trading mixed Friday.

bitcoin copy

Stock Market Today With Jim Cramer: China's Crypto Clampdown

Jim Cramer discusses China's crypto clampdown and Nike's report.